A. T. Ozdogar Et Al. , "The Efficacy of Fampridine on Upper Extremity Functions in Individuals with Multiple Sclerosis: Is There a Difference between Cerebellar and Pyramidal Dysfunction?," Journal of Multiple Sclerosis Research , vol.1, no.1, pp.75-78, 2021
Ozdogar, A. T. Et Al. 2021. The Efficacy of Fampridine on Upper Extremity Functions in Individuals with Multiple Sclerosis: Is There a Difference between Cerebellar and Pyramidal Dysfunction?. Journal of Multiple Sclerosis Research , vol.1, no.1 , 75-78.
Ozdogar, A. T., Ozcelik, S., & Dastan, S., (2021). The Efficacy of Fampridine on Upper Extremity Functions in Individuals with Multiple Sclerosis: Is There a Difference between Cerebellar and Pyramidal Dysfunction?. Journal of Multiple Sclerosis Research , vol.1, no.1, 75-78.
Ozdogar, Asiye, SİNEM ÖZÇELİK, And Seda Dastan. "The Efficacy of Fampridine on Upper Extremity Functions in Individuals with Multiple Sclerosis: Is There a Difference between Cerebellar and Pyramidal Dysfunction?," Journal of Multiple Sclerosis Research , vol.1, no.1, 75-78, 2021
Ozdogar, Asiye T. Et Al. "The Efficacy of Fampridine on Upper Extremity Functions in Individuals with Multiple Sclerosis: Is There a Difference between Cerebellar and Pyramidal Dysfunction?." Journal of Multiple Sclerosis Research , vol.1, no.1, pp.75-78, 2021
Ozdogar, A. T. Ozcelik, S. And Dastan, S. (2021) . "The Efficacy of Fampridine on Upper Extremity Functions in Individuals with Multiple Sclerosis: Is There a Difference between Cerebellar and Pyramidal Dysfunction?." Journal of Multiple Sclerosis Research , vol.1, no.1, pp.75-78.
@article{article, author={Asiye Tuba Ozdogar Et Al. }, title={The Efficacy of Fampridine on Upper Extremity Functions in Individuals with Multiple Sclerosis: Is There a Difference between Cerebellar and Pyramidal Dysfunction?}, journal={Journal of Multiple Sclerosis Research}, year=2021, pages={75-78} }